CD4 + T cells contribute to neurodegeneration in Lewy body dementia
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CD4
+
T cells contribute to neurodegeneration in Lewy body dementia
Authors
Keywords
-
Journal
SCIENCE
Volume 374, Issue 6569, Pages 868-874
Publisher
American Association for the Advancement of Science (AAAS)
Online
2021-10-15
DOI
10.1126/science.abf7266
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Methods to investigate intrathecal adaptive immunity in neurodegeneration
- (2021) Hamilton Oh et al. Molecular Neurodegeneration
- The TCR repertoire of α-synuclein-specific T cells in Parkinson’s disease is surprisingly diverse
- (2021) Akul Singhania et al. Scientific Reports
- Diagnosis and Treatment of Parkinson Disease
- (2020) Melissa J. Armstrong et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer’s disease
- (2020) David Gate et al. NATURE
- α-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson’s disease
- (2020) Cecilia S. Lindestam Arlehamn et al. Nature Communications
- Neuroinflammation is associated with infiltration of T cells in Lewy body disease and α-synuclein transgenic models
- (2020) Michiyo Iba et al. Journal of Neuroinflammation
- Cytoskeletal Control of Antigen-Dependent T Cell Activation
- (2019) Huw Colin-York et al. Cell Reports
- Killer-like receptors and GPR56 progressive expression defines cytokine production of human CD4+ memory T cells
- (2019) Kim-Long Truong et al. Nature Communications
- Th17 Lymphocytes Induce Neuronal Cell Death in a Human iPSC-Based Model of Parkinson’s Disease
- (2018) Annika Sommer et al. Cell Stem Cell
- T cells from patients with Parkinson’s disease recognize α-synuclein peptides
- (2017) David Sulzer et al. NATURE
- Diagnosis and management of dementia with Lewy bodies
- (2017) Ian G. McKeith et al. NEUROLOGY
- Th17 Cells Induce Dopaminergic Neuronal Death via LFA-1/ICAM-1 Interaction in a Mouse Model of Parkinson’s Disease
- (2016) Zhan Liu et al. MOLECULAR NEUROBIOLOGY
- Lewy body dementias
- (2015) Zuzana Walker et al. LANCET
- CXCR4 Inhibition with AMD3100 Sensitizes Prostate Cancer to Docetaxel Chemotherapy
- (2015) Urszula M. Domanska et al. NEOPLASIA
- MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration
- (2014) Carolina Cebrián et al. Nature Communications
- MHCII Is Required for -Synuclein-Induced Activation of Microglia, CD4 T Cell Proliferation, and Dopaminergic Neurodegeneration
- (2013) A. S. Harms et al. JOURNAL OF NEUROSCIENCE
- Th17 Cell-Mediated Neuroinflammation Is Involved in Neurodegeneration of Aβ1-42-Induced Alzheimer’s Disease Model Rats
- (2013) Jun Zhang et al. PLoS One
- CD4+ Regulatory and Effector/Memory T Cell Subsets Profile Motor Dysfunction in Parkinson’s Disease
- (2012) Jessica A. Hutter Saunders et al. Journal of Neuroimmune Pharmacology
- Reduced T helper and B lymphocytes in Parkinson's disease
- (2012) Claire H. Stevens et al. JOURNAL OF NEUROIMMUNOLOGY
- Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines
- (2012) Irene Litvan et al. MOVEMENT DISORDERS
- CD161 is a marker of all human IL-17-producing T-cell subsets and is induced by RORC
- (2010) Laura Maggi et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The Novel CXCR4 Antagonist KRH-3955 Is an Orally Bioavailable and Extremely Potent Inhibitor of Human Immunodeficiency Virus Type 1 Infection: Comparative Studies with AMD3100
- (2009) T. Murakami et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficient inhibition of SDF-1α-mediated chemotaxis and HIV-1 infection by novel CXCR4 antagonists
- (2009) Yuki Iwasaki et al. CANCER SCIENCE
- C-C chemokine receptor 6–regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE
- (2009) Andrea Reboldi et al. NATURE IMMUNOLOGY
- Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100
- (2008) B. Nervi et al. BLOOD
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search